Last10K.com

Biotechne Corp (TECH) SEC Filing 8-K Material Event for the period ending Friday, October 26, 2018

Biotechne Corp

CIK: 842023 Ticker: TECH

View differences made from one to another to evaluate Biotechne Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biotechne Corp.

Continue

Assess how Biotechne Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biotechne Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: TECH
CIK: 842023
Form Type: 8-K Corporate News
Accession Number: 0001437749-18-018887
Submitted to the SEC: Fri Oct 26 2018 4:09:25 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tech/0001437749-18-018887.htm